GM-CSF induces inflammatory macrophages by regulating glycolysis and lipid metabolism

Journal of Immunology

Volumn 197, Issue 10, 2016, Pages 4101-4109

  Na, Yi Rang ^a   Gu, Gyo Jung ^a   Jung, Daun ^a   Kim, Young Won ^a   Na, Juri ^a,b   Woo, Jin Sun ^a   Cho, Joo Youn ^a   Youn, Hyewon ^b,c   Seok, Seung Hyeok ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; DEOXYGLUCOSE; DEXTRAN SULFATE; FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 4; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MEVALONIC ACID; MYC PROTEIN; TUMOR NECROSIS FACTOR; CYTOKINE; HYDROXYMETHYLGUTARYL-COA HYDROLASE; SLC2A1 PROTEIN, MOUSE; THIOL ESTER HYDROLASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PH; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; GLUCOSE TRANSPORT; GLYCOLYSIS; HMGCR GENE; IL 12P40 GENE; IL 1BETA GENE; IL 6 GENE; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TNF ALPHA GENE; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL CULTURE; CELL LINE; COLON; CYTOLOGY; DRUG EFFECTS; GENETICS; IMMUNOLOGY; MACROPHAGE; METABOLISM; ONCOGENE MYC; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CELL LINE; CELLS, CULTURED; COLON; CYTOKINES; DEOXYGLUCOSE; FLUORODEOXYGLUCOSE F18; GENES, MYC; GLUCOSE TRANSPORTER TYPE 1; GLYCOLYSIS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERLEUKIN-1BETA; LIPID METABOLISM; MACROPHAGES; MICE; POSITRON-EMISSION TOMOGRAPHY; THIOLESTER HYDROLASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84994452826     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600745     Document Type: Article

References (44)

1. Wynn, T. A., A. Chawla, and J. W. Pollard. 2013. Macrophage biology in development, homeostasis and disease. Nature 496: 445-455.
2. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8: 958-969.
3. Murray, P. J., J. E. Allen, S. K. Biswas, E. A. Fisher, D. W. Gilroy, S. Goerdt, S. Gordon, J. A. Hamilton, L. B. Ivashkiv, T. Lawrence, et al. 2014. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41: 14-20.
4. Lawrence, T., and G. Natoli. 2011. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11: 750-761.
5. Pearce, E. L., and E. J. Pearce. 2013. Metabolic pathways in immune cell activation and quiescence. Immunity 38: 633-643.
6. Araki, K., A. P. Turner, V. O. Shaffer, S. Gangappa, S. A. Keller, M. F. Bachmann, C. P. Larsen, and R. Ahmed. 2009. mTOR regulates memory CD8 T-cell differentiation. Nature 460: 108-112.
7. Frauwirth, K. A., J. L. Riley, M. H. Harris, R. V. Parry, J. C. Rathmell, D. R. Plas, R. L. Elstrom, C. H. June, and C. B. Thompson. 2002. The CD28 signaling pathway regulates glucose metabolism. Immunity 16: 769-777.
8. Gerriets, V. A., and J. C. Rathmell. 2012. Metabolic pathways in T cell fate and function. Trends Immunol. 33: 168-173.
9. van der Windt, G. J., and E. L. Pearce. 2012. Metabolic switching and fuel choice during T-cell differentiation and memory development. Immunol. Rev. 249: 27-42.
10. Everts, B., E. Amiel, S. C. Huang, A. M. Smith, C. H. Chang, W. Y. Lam, V. Redmann, T. C. Freitas, J. Blagih, G. J. van der Windt, et al. 2014. TLR-driven early glycolytic reprogramming via the kinases TBK1-IKK supports the anabolic demands of dendritic cell activation. Nat. Immunol. 15: 323-332.
11. Everts, B., E. Amiel, G. J. van derWindt, T. C. Freitas, R. Chott, K. E. Yarasheski, E. L. Pearce, and E. J. Pearce. 2012. Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells. Blood 120: 1422-1431.
12. Jantsch, J., D. Chakravortty, N. Turza, A. T. Prechtel, B. Buchholz, R. G. Gerlach, M. Volke, J. Gläsner, C. Warnecke, M. S. Wiesener, et al. 2008. Hypoxia and hypoxia-inducible factor-1 alpha modulate lipopolysaccharideinduced dendritic cell activation and function. J. Immunol. 180: 4697-4705.
13. Krawczyk, C. M., T. Holowka, J. Sun, J. Blagih, E. Amiel, R. J. DeBerardinis, J. R. Cross, E. Jung, C. B. Thompson, R. G. Jones, and E. J. Pearce. 2010. Tolllike receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 115: 4742-4749.
14. Galván-Peña, S., and L. A. O'Neill. 2014. Metabolic reprograming in macrophage polarization. Front. Immunol. 5: 420.
15. Biswas, S. K., and A. Mantovani. 2012. Orchestration of metabolism by macrophages. Cell Metab. 15: 432-437.
16. Na, Y. R., J. H. Hong, M. Y. Lee, J. H. Jung, D. Jung, Y. W. Kim, D. Son, M. Choi, K. P. Kim, Jr., and S. H. Seok. 2015. Proteomic analysis reveals distinct metabolic differences between GM-CSF and M-CSF grown macrophages derived from murine bone marrow cells. Mol. Cell. Proteomics 14: 2722-2732.
17. Hercus, T. R., D. Thomas, M. A. Guthridge, P. G. Ekert, J. King-Scott, M. W. Parker, and A. F. Lopez. 2009. The granulocyte-macrophage colonystimulating factor receptor: linking its structure to cell signaling and its role in disease. Blood 114: 1289-1298.
18. Fleetwood, A. J., A. D. Cook, and J. A. Hamilton. 2005. Functions of granulocytemacrophage colony-stimulating factor. Crit. Rev. Immunol. 25: 405-428.
19. Nakata, K., K. S. Akagawa, M. Fukayama, Y. Hayashi, M. Kadokura, and T. Tokunaga. 1991. Granulocyte-macrophage colony-stimulating factor promotes the proliferation of human alveolar macrophages in vitro. J. Immunol. 147: 1266-1272.
20. Hamilton, J. A. 2008. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 8: 533-544.
21. Haschemi, A., P. Kosma, L. Gille, C. R. Evans, C. F. Burant, P. Starkl, B. Knapp, R. Haas, J. A. Schmid, C. Jandl, et al. 2012. The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism. Cell Metab. 15: 813-826.
22. Brewer, S., M. McPherson, D. Fujiwara, O. Turovskaya, D. Ziring, L. Chen, H. Takedatsu, S. R. Targan, B. Wei, and J. Braun. 2008. Molecular imaging of murine intestinal inflammation with 2-deoxy-2-[18F]fluoro-D-glucose and positron emission tomography. Gastroenterology 135: 744-755.
23. Fleetwood, A. J., T. Lawrence, J. A. Hamilton, and A. D. Cook. 2007. Granulocytemacrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J. Immunol. 178: 5245-5252.
24. Lacey, D. C., A. Achuthan, A. J. Fleetwood, H. Dinh, J. Roiniotis, G. M. Scholz, M. W. Chang, S. K. Beckman, A. D. Cook, and J. A. Hamilton. 2012. Defining GM-CSF-and macrophage-CSF-dependent macrophage responses by in vitro models. J. Immunol. 188: 5752-5765.
25. Freemerman, A. J., A. R. Johnson, G. N. Sacks, J. J. Milner, E. L. Kirk, M. A. Troester, A. N. Macintyre, P. Goraksha-Hicks, J. C. Rathmell, and L. Makowski. 2014. Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype. J. Biol. Chem. 289: 7884-7896.
26. Wang, R., C. P. Dillon, L. Z. Shi, S. Milasta, R. Carter, D. Finkelstein, L. L. McCormick, P. Fitzgerald, H. Chi, J. Munger, and D. R. Green. 2011. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35: 871-882.
27. Dang, C. V., K. A. O'Donnell, K. I. Zeller, T. Nguyen, R. C. Osthus, and F. Li. 2006. The c-Myc target gene network. Semin. Cancer Biol. 16: 253-264.
28. Eilers, M., and R. N. Eisenman. 2008. Myc's broad reach. Genes Dev. 22: 2755-2766.
29. Xu, X., L. Ye, K. Araki, and R. Ahmed. 2012. mTOR, linking metabolism and immunity. Semin. Immunol. 24: 429-435.
30. Istvan, E. S., and J. Deisenhofer. 2001. Structural mechanism for statin inhibition of HMG-CoA reductase. Science 292: 1160-1164.
31. Du, C., P. Wang, Y. Yu, F. Chen, J. Liu, and Y. Li. 2014. Gadolinium chloride improves the course of TNBS and DSS-induced colitis through protecting against colonic mucosal inflammation. Sci. Rep. 4: 6096.
32. Muthupalani, S., Z. Ge, Y. Feng, B. Rickman, M. Mobley, A. McCabe, N. Van Rooijen, and J. G. Fox. 2012. Systemic macrophage depletion inhibits Helicobacter bilis-induced proinflammatory cytokine-mediated typhlocolitis and impairs bacterial colonization dynamics in a BALB/c Rag2-/-mouse model of inflammatory bowel disease. Infect. Immun. 80: 4388-4397.
33. Gordan, J. D., C. B. Thompson, andM. C. Simon. 2007. HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell 12: 108-113.
34. Dang, C. V. 2010. Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. Cancer Res. 70: 859-862.
35. Tannahill, G. M., A. M. Curtis, J. Adamik, E. M. Palsson-McDermott, A. F. McGettrick, G. Goel, C. Frezza, N. J. Bernard, B. Kelly, N. H. Foley, et al. 2013. Succinate is an inflammatory signal that induces IL-1b through HIF-1a. Nature 496: 238-242.
36. Hayek, T., M. Kaplan, R. Kerry, and M. Aviram. 2007. Macrophage NADPH oxidase activation, impaired cholesterol fluxes, and increased cholesterol biosynthesis in diabetic mice: a stimulatory role for D-glucose. Atherosclerosis 195: 277-286.
37. Kaplan, M., R. Kerry, M. Aviram, and T. Hayek. 2008. High glucose concentration increases macrophage cholesterol biosynthesis in diabetes through activation of the sterol regulatory element binding protein 1 (SREBP1): inhibitory effect of insulin. J. Cardiovasc. Pharmacol. 52: 324-332.
38. O'Rourke, L., L. M. Gronning, S. J. Yeaman, and P. R. Shepherd. 2002. Glucosedependent regulation of cholesterol ester metabolism in macrophages by insulin and leptin. J. Biol. Chem. 277: 42557-42562.
39. Porstmann, T., B. Griffiths, Y. L. Chung, O. Delpuech, J. R. Griffiths, J. Downward, and A. Schulze. 2005. PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene 24: 6465-6481.
40. Pahan, K., F. G. Sheikh, A. M. Namboodiri, and I. Singh. 1997. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J. Clin. Invest. 100: 2671-2679.
41. Aktas, O., S. Waiczies, A. Smorodchenko, J. Dorr, B. Seeger, T. Prozorovski, S. Sallach, M. Endres, S. Brocke, R. Nitsch, and F. Zipp. 2003. Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin. J. Exp. Med. 197: 725-733.
42. Youssef, S., O. Stüve, J. C. Patarroyo, P. J. Ruiz, J. L. Radosevich, E. M. Hur, M. Bravo, D. J. Mitchell, R. A. Sobel, L. Steinman, and S. S. Zamvil. 2002. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420: 78-84.
43. Im, S. S., L. Yousef, C. Blaschitz, J. Z. Liu, R. A. Edwards, S. G. Young, M. Raffatellu, and T. F. Osborne. 2011. Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. Cell Metab. 13: 540-549.
44. Zhang, F. L., and P. J. Casey. 1996. Protein prenylation: molecular mechanisms and functional consequences. Annu. Rev. Biochem. 65: 241-269.